Dr. Hantel is a faculty member in the Divisions of Population Sciences and Leukemia at DFCI and an Instructor in Medicine at Harvard Medical School. His research focuses on characterizing and remediating clinical trial enrollment disparities for patients with blood cancers, for which he has been awarded career development awards from the NCI (K08) and ASCO to develop and test related multilevel interventions. He also leads multicenter care delivery trials assessing social determinants of health and the impact of Duffy null phenotype on trial participation and outcomes. Work related to these projects has led to multiple publications in journals such as in JAMA, JCO, JNCI, and NEJM. He co-chairs the working group of the DFCI Clinical Trial Access Committee and serves as the Health Disparities and Leukemia Committee Liaison for the Alliance cooperative group. In his clinical role, he cares for patients with leukemia and related hematologic malignancies.